Please login to the form below

Not currently logged in
Email:
Password:

FTI Consulting appoints Andrew Ward

He joins the healthcare communications practice as managing director

Andrew WardFTI Consulting, a life science and healthcare communications practice, has appointed a new managing director in the form of Andrew Ward.

Ward joins the group from the Financial Times, where he was the pharmaceuticals correspondent for almost three years, covering the business, finance, science and regulation of the global pharmaceuticals and medical equipment industries.

Ben Atwell, senior managing director and global head of life sciences and healthcare at FTI Consulting Strategic Communications, said: “Andrew was one of the sector’s most respected reporters during his time covering healthcare, and brings invaluable global perspective to our prestigious client base.

“We look forward to benefiting from his deep media experience and welcoming him to our global team of over 50 healthcare experts.”

In his new role, Ward will broaden and deepen FTI Consulting’s client base globally.

He said: “I am excited to be joining the best communications practice in the healthcare sector.

“It is a difficult decision to leave the FT after 18 fantastic years but the opportunity to help industries was too good to turn down.”

6th April 2018

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics